Physician

Derik Scribner, D.O.

According to 2025 Medicare claims, Derik Scribner, D.O. (NPI: 1205221991) practices physical medicine and rehabilitation in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (NPI: 1518589803; TIN: 850900392) and primary practice location at 45801-5900.

Scribner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 291 traditional Medicare patients, billed 25,506 HCPCS/CPT codes, and received $234,673 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,590 prescription claims across 192 beneficiaries totaling $107,708 in drug costs, led by Buprenorphine (Buprenorphine). Open Payments data shows 6 records totaling $137. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $10,323 to $234,673. Similarly, Part D prescription costs have risen steadily, from $2,385 to $107,708. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$117K$235K2020 Medicare payment: $10,323 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $130,209 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $183,014 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $193,748 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $234,673 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202038305$10,323
20211668,764$130,209
202223315,404$183,014
202326920,748$193,748
202429125,506$234,673

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$54K$108K2015 Drug cost: $2,385 (USD; Tot_Drug_Cst)2016 Drug cost: $35,273 (USD; Tot_Drug_Cst)2017 Drug cost: $10,719 (USD; Tot_Drug_Cst)2018 Drug cost: $2,885 (USD; Tot_Drug_Cst)2019 Drug cost: $1,340 (USD; Tot_Drug_Cst)2020 Drug cost: $7,166 (USD; Tot_Drug_Cst)2021 Drug cost: $57,073 (USD; Tot_Drug_Cst)2022 Drug cost: $58,176 (USD; Tot_Drug_Cst)2023 Drug cost: $100,229 (USD; Tot_Drug_Cst)2024 Drug cost: $107,708 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R50$2,385
20162080$35,273
201721169$10,719
20181379$2,885
20193561$1,340
202085246$7,166
20212091,200$57,073
20222191,541$58,176
20232011,638$100,229
20241921,590$107,708

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more100208$84
62323Injection of substance into lower spine canal using imaging guidance4654$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more68125$64
99152Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes87115$9
J0585Injection, onabotulinumtoxina, 1 unit4423,900$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BuprenorphineBuprenorphine701,964$21,378
NucyntaTapentadol Hcl25750$18,408
PregabalinPregabalin2388,304$7,967
BelbucaBuprenorphine Hcl14374$6,511
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2617,520$4,801

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$137Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Derik Scribner, D.O.?

Tedicare shows public-source Medicare data for Derik Scribner, D.O. (NPI 1205221991), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Derik Scribner, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Derik Scribner, D.O.?

Derik Scribner, D.O. is linked to MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (billing NPI 1518589803) in the available physician profile data.

Does Derik Scribner, D.O. have Open Payments data?

Derik Scribner, D.O. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.